Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study
NCT05693363 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-01-15
Summary
In this pilot study the investigators propose the intraoperative use of a high-resolution PET-CT imaging system which can assess resection margins and lymph node status in the operating room. This will allow for a faster and stepwise assessment (estimated to be under 10 minutes per specimen), enabling the surgeon to decide on subsequent surgical steps after each previous assessment.
Conditions
- Lung Neoplasms
- PET-CT Specimen Imager
Interventions
- DEVICE
-
AURA10 Specimen Imager
High-resolution specimen imaging using the AURA10 PET-CT specimen imager during thoracic surgery.
Sponsors & Collaborators
-
XEOS Medical
collaborator INDUSTRY -
University Hospital, Ghent
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2025-07-31
- Completion
- 2025-07-31
Countries
- Belgium
Study Locations
More Related Trials
-
Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy
NCT06726512 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors
NCT01075399 ·Status: COMPLETED ·Phase: PHASE2
-
Imaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
NCT06107374 ·Status: RECRUITING ·Phase: PHASE2
-
Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT
NCT05068687 ·Status: COMPLETED ·Phase: NA
-
An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiation
NCT01260480 ·Status: UNKNOWN ·Phase: PHASE2
-
PD-L1 PET Imaging in Melanoma Patients
NCT03520634 ·Status: COMPLETED ·Phase: NA
-
Test-retest Evaluation of [18F]F-AraG PET
NCT06084806 ·Status: RECRUITING ·Phase: PHASE2
-
The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer
NCT00380666 ·Status: WITHDRAWN ·Phase: NA
-
FDG PET/CT in Lung Cancer Staging
NCT02738398 ·Status: COMPLETED ·Phase: NA
-
Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC
NCT00697333 ·Status: UNKNOWN ·Phase: PHASE2
-
PET With Respiratory Gating Technique in Evaluation of Response and Normal Tissue Effect in Thoracic Cancer
NCT02063633 ·Status: UNKNOWN
-
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
NCT04726215 ·Status: UNKNOWN ·Phase: PHASE2
-
Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy
NCT03493789 ·Status: COMPLETED ·Phase: PHASE1
-
RefleXion PET/CT Imaging Performance in Patients With Various Malignancies
NCT05844306 ·Status: SUSPENDED ·Phase: NA
-
FDG-Positron Emission Tomography (PET)/CT In the Evaluation of Persistent Febrile Neutropenia in Cancer Patients
NCT00707213 ·Status: TERMINATED ·Phase: PHASE1
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager
NCT03561324 ·Status: WITHDRAWN ·Phase: NA
-
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
NCT04678440 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Feasibility Study on the Use of F-18-FDG-PET and Optical Imaging in Evaluation of Radiation-induced Oral Mucositis
NCT01077869 ·Status: TERMINATED
-
F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer
NCT06789562 ·Status: NOT_YET_RECRUITING
-
18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma
NCT05096234 ·Status: TERMINATED ·Phase: PHASE1
-
Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study
NCT00686465 ·Status: COMPLETED ·Phase: NA
-
A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors
NCT04260256 ·Status: TERMINATED ·Phase: PHASE2
-
Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
NCT00522639 ·Status: TERMINATED ·Phase: PHASE3
-
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
NCT04721756 ·Status: UNKNOWN ·Phase: EARLY_PHASE1